miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is the eighth most common cancer worldwide and is one of the most lethal malignancies. Cisplatin (DDP) is a key drug for ESCC treatment, but the presence of chemotherapy resistance limits the use of DDP. To enhance chemosensitivity to DDP is impo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Cell Int
Hlavní autoři: Zheng, Tian-Liang, Li, De-Ping, He, Zhan-Feng, Zhao, Song
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Primary Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6767650/
https://ncbi.nlm.nih.gov/pubmed/31582906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0943-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky